News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biote Corp. - Class A common stock
(NQ:
BTMD
)
5.100
-0.020 (-0.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biote Corp. - Class A common stock
< Previous
1
2
Next >
Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call
October 29, 2024
From
biote Corp.
Via
Business Wire
Biote Reports Second Quarter 2024 Financial Results
August 08, 2024
From
biote Corp.
Via
Business Wire
Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call
July 25, 2024
From
biote Corp.
Via
Business Wire
Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares
June 20, 2024
From
biote Corp.
Via
Business Wire
Biote Reports First Quarter 2024 Financial Results
May 07, 2024
From
Biote
Via
Business Wire
Biote Announces Definitive Settlement with Founder
April 29, 2024
From
biote Corp.
Via
Business Wire
Biote Schedules First Quarter 2024 Financial Results Release and Conference Call
April 23, 2024
From
biote Corp.
Via
Business Wire
Biote Reports Fourth Quarter and Full Year 2023 Financial Results
March 12, 2024
From
Biote
Via
Business Wire
Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call
February 27, 2024
From
Biote Corp.
Via
Business Wire
Biote Announces Agreement to Resolve Litigation and Repurchase All of Founder’s Shares
February 20, 2024
From
biote Corp.
Via
Business Wire
Biote Announces $20 Million Share Repurchase Authorization
January 25, 2024
From
biote Corp.
Via
Business Wire
Biote Provides Preliminary 2023 Results and Initial 2024 Guidance
January 17, 2024
From
biote Corp.
Via
Business Wire
Biote to Purchase Asteria Health
January 17, 2024
From
biote Corp.
Via
Business Wire
Biote Names Robert Peterson as Chief Financial Officer
January 11, 2024
From
biote Corp.
Via
Business Wire
Biote Reports Third Quarter 2023 Financial Results
November 07, 2023
From
Biote
Via
Business Wire
Biote Schedules Third Quarter 2023 Financial Results Release and Conference Call
October 24, 2023
From
biote Corp.
Via
Business Wire
Biote Reports Second Quarter 2023 Financial Results
August 10, 2023
From
Biote
Via
Business Wire
Biote Schedules Second Quarter 2023 Financial Results Release and Conference Call
July 27, 2023
From
biote Corp.
Via
Business Wire
Biote Formalizes Commitment to Men’s Hormone Health With Launch of New Men’s Health Division
June 22, 2023
From
biote Corp.
Via
Business Wire
InvestorNewsBreaks – Biote Corp. (NASDAQ: BTMD) Closes $31M Underwritten Public Offering
June 13, 2023
Via
Investor Brand Network
Biote Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants
June 08, 2023
From
Biote
Via
Business Wire
Biote Announces Pricing of Secondary Offering of Common Stock
June 05, 2023
From
biote Corp
Via
Business Wire
Biote to Participate at Upcoming Investor Conferences
May 31, 2023
From
biote Corp.
Via
Business Wire
Biote Appoints Mary J. Puncochar as Chief Commercial Officer
May 30, 2023
From
biote Corp.
Via
Business Wire
Biote Reports First Quarter 2023 Financial Results
May 09, 2023
From
Biote
Via
Business Wire
Biote Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants
May 09, 2023
From
Biote
Via
Business Wire
Biote Schedules First Quarter 2023 Financial Results Release and Conference Call
April 26, 2023
From
biote Corp.
Via
Business Wire
Biote Names John Denne as General Manager, Men’s Health Division
April 10, 2023
From
Biote
Via
Business Wire
Biote Reports Fourth Quarter and Full Year 2022 Financial Results
March 28, 2023
From
Biote
Via
Business Wire
Study: Testosterone Pellet Therapy Significantly Improves Bone Density in Male Patient Case Report
March 27, 2023
From
Biote
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.